Patents by Inventor Christina CAPACCI-DANIEL

Christina CAPACCI-DANIEL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds for the treatment of conditions associated with DGAT1 activity
    Patent number: 9242971
    Abstract: The present invention relates to novel crystalline forms of salts of 2-((1R,4R)-4-(4-(5-(benzo[d]oxazol-2-ylamino)pyridin-2-yl)phenyl)cyclohexyl)acetic acid and their use in the treatment or prevention of a condition or a disorder associated with DGAT1 activity in animals, particularly humans.
    Type: Grant
    Filed: February 24, 2015
    Date of Patent: January 26, 2016
    Assignee: NOVARTIS AG
    Inventors: Christina Capacci-Daniel, Marilyn Delacruz, Baoqing Gong, Akash Jain, Yansong Lu, Lijun Zhang
  • COMPOUNDS FOR THE TREATMENT OF CONDITIONS ASSOCIATED WITH DGAT1 ACTIVITY
    Publication number: 20150166522
    Abstract: The present invention relates to novel crystalline forms of salts of 2-((1R,4R)-4-(4-(5-(benzo[d]oxazol-2-ylamino)pyridin-2-yl)phenyl)cyclohexyl)acetic acid and their use in the treatment or prevention of a condition or a disorder associated with DGAT1 activity in animals, particularly humans.
    Type: Application
    Filed: February 24, 2015
    Publication date: June 18, 2015
    Applicant: NOVARTIS AG
    Inventors: Christina CAPACCI-DANIEL, Marilyn DELACRUZ, Baoqing GONG, Akash JAIN, Yansong LU, Lijun ZHANG
  • Compounds for the treatment of conditions associated with DGAT1 activity
    Patent number: 8987459
    Abstract: The present invention relates to novel crystalline forms of salts of 2-((1R,4R)-4-(4-(5-(benzo[d]oxazol-2-ylamino)pyridin-2-yl)phenyl)cyclohexyl)acetic acid and their use in the treatment or prevention of a condition or a disorder associated with DGAT1 activity in animals, particularly humans.
    Type: Grant
    Filed: January 10, 2014
    Date of Patent: March 24, 2015
    Assignee: Novartis AG
    Inventors: Christina Capacci-Daniel, Marilyn DeLaCruz, Baoqing Gong, Akash Jain, Yansong Lu, Lijun Zhang
  • COMPOUNDS FOR THE TREATMENT OF CONDITIONS ASSOCIATED WITH DGAT1 ACTIVITY
    Publication number: 20140200246
    Abstract: The present invention relates to novel crystalline forms of salts of 2-((1R,4R)-4-(4-(5-(benzo[d]oxazol-2-ylamino)pyridin-2-yl)phenyl)cyclohexyl)acetic acid and their use in the treatment or prevention of a condition or a disorder associated with DGAT1 activity in animals, particularly humans.
    Type: Application
    Filed: January 10, 2014
    Publication date: July 17, 2014
    Applicant: NOVARTIS AG
    Inventors: Christina CAPACCI-DANIEL, Marilyn DELACRUZ, Baoqing GONG, Akash JAIN, Yansong LU, Lijun ZHANG